1 |
World Health Organization. Global tuberculosis report 2022 [EB/OL]. (2022-10-17) [2023-04-19]. https://www.who.int/publications/i/item/9789240061729.
|
2 |
SIQUEIRA M D S, RIBEIRO R M, TRAVASSOS L H. Autophagy and its interaction with intracellular bacterial pathogens[J]. Front Immunol, 2018, 9: 935.
|
3 |
STUTZ M D, ALLISON C C, OJAIMI S, et al. Macrophage and neutrophil death programs differentially confer resistance to tuberculosis[J]. Immunity, 2021, 54(8): 1758-1771.e7.
|
4 |
TUR J, PEREIRA-LOPES S, VICO T, et al. Mitofusin 2 in macrophages links mitochondrial ROS production, cytokine release, phagocytosis, autophagy, and bactericidal activity[J]. Cell Rep, 2020, 32(8): 108079.
|
5 |
ZHAI W J, WU F J, ZHANG Y Y, et al. The immune escape mechanisms of Mycobacterium tuberculosis[J]. Int J Mol Sci, 2019, 20(2): 340.
|
6 |
FABIAN M R, SONENBERG N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC[J]. Nat Struct Mol Biol, 2012, 19(6): 586-593.
|
7 |
SAMPATH P, PERIYASAMY K M, RANGANATHAN U D, et al. Monocyte and macrophage miRNA: potent biomarker and target for host-directed therapy for tuberculosis[J]. Front Immunol, 2021, 12: 667206.
|
8 |
CHANDAN K, GUPTA M, SARWAT M. Role of host and pathogen-derived microRNAs in immune regulation during infectious and inflammatory diseases[J]. Front Immunol, 2019, 10: 3081.
|
9 |
KAUSHIK A C, WU Q Q, LIN L, et al. Exosomal ncRNAs profiling of mycobacterial infection identified miRNA-185-5p as a novel biomarker for tuberculosis[J]. Brief Bioinform, 2021, 22(6): bbab210.
|
10 |
GUTIERREZ M G, MASTER S S, SINGH S B, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages[J]. Cell, 2004, 119(6): 753-766.
|
11 |
LAM A, PRABHU R, GROSS C M, et al. Role of apoptosis and autophagy in tuberculosis[J]. Am J Physiol Lung Cell Mol Physiol, 2017, 313(2): L218-L229.
|
12 |
CHANDRA V, BHAGYARAJ E, NANDURI R, et al. NR1D1 ameliorates Mycobacterium tuberculosis clearance through regulation of autophagy[J]. Autophagy, 2015, 11(11): 1987-1997.
|
13 |
MINOWA-NOZAWA A, NOZAWA T, OKAMOTO-FURUTA K, et al. Rab35 GTPase recruits NDP52 to autophagy targets[J]. EMBO J, 2017, 36(18): 2790-2807.
|
14 |
LI C S, LI Z Z, SONG L X, et al. GEFT inhibits autophagy and apoptosis in rhabdomyosarcoma via activation of the Rac1/Cdc42-mTOR signaling pathway[J]. Front Oncol, 2021, 11: 656608.
|
15 |
LIU Y H, NIE H G, DING Y, et al. MiRNA, a new treatment strategy for pulmonary fibrosis[J]. Curr Drug Targets, 2021, 22(7): 793-802.
|
16 |
HINKEL R, RAMANUJAM D, KACZMAREK V, et al. AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia/reperfusion injury[J]. J Am Coll Cardiol, 2020, 75(15): 1788-1800.
|
17 |
LIANG Y, DUAN L, LU J, et al. Engineering exosomes for targeted drug delivery[J]. Theranostics, 2021, 11(7): 3183-3195.
|
18 |
LIANG G F, ZHU Y L, ALI D J, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J]. J Nanobiotechnology, 2020, 18(1): 10.
|
19 |
CHANDRA V, MAHAJAN S, SAINI A, et al. Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance[J]. J Biol Chem, 2013, 288(15): 10692-10702.
|
20 |
MA X R, LIU H F, ZHU J, et al. MiR-185-5p regulates inflammation and phagocytosis through CDC42/JNK pathway in macrophages[J]. Genes (Basel), 2022, 13(3): 468.
|
21 |
YE Y, LIU J, GUO Y, et al. PPARγ ameliorates Mycobacterium tuberculosis H37Ra-induced foamy macrophage formation via the ABCG1-dependent cholesterol efflux pathway in THP-1 macrophages[J]. Front Microbiol, 2022, 13: 829870.
|
22 |
HÖLSCHER C, GRÄB J, HÖLSCHER A, et al. Chemical p38 MAP kinase inhibition constrains tissue inflammation and improves antibiotic activity in Mycobacterium tuberculosis-infected mice[J]. Sci Rep, 2020, 10(1): 13629.
|